Engineering CAR-NK Cells for Solid Tumors
Kilder
- Nature: OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumours - Nature
- Nature: Stem cells provide a potent treatment for frailty - Nature
- Fiercebiotech: After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate - Fierce Biotech
- Fiercebiotech: GSK pays $950M in cash for Canadian biotech and its Winrevair-like blood pressure drug - Fierce Biotech
- Statnews: Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugs - statnews.com
- Biopharmadive: BreezeBio banks $60M to make more precise genetic medicines - BioPharma Dive
- wikimedia: Photo by Nantavisai et al. (2020) / Wikimedia Commons / CC BY 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.